Category: trials

  • Best Altcoins to Buy as Thailand Trials Crypto Trading

    It seems that the Securities and Stock Exchange Committee (SEC) in Thailand is scheduled to offer the Distributed Professor Technology Trading platform (DLT) for securities. The initiative aims to take advantage of the wide investor networks to facilitate digital symbolic transactions. In this process, the SEC decision in Thailand achieves…

  • AbbVie tumbles after new schizophrenia drug fails two trials

    (Bloomberg) — AbbVie Inc. shares fell. (ABBV) fell by the most in three years after two mid-stage trials of its schizophrenia drug failed to meet their primary target, a blow to the company’s $8.7 billion acquisition of Cerevel Therapeutics earlier this year. . Most read from Bloomberg AbbVie said Monday…

  • Defense Ministry trials display drone interception solutions

    Yesterday, the Ministry of Defense conducted experiments in southern Israel in which Israeli startups and veteran defense companies demonstrated technologies and systems for intercepting drones. The trials were held following the deadly Hezbollah drone attack on an Israeli army base near Binyamina. The trials were attended by Defense Minister Yoav…

  • Defense Ministry trials display drone interception solutions

    Yesterday, the Ministry of Defense conducted experiments in southern Israel in which Israeli startups and veteran defense companies demonstrated technologies and systems for intercepting drones. The trials were held following the deadly Hezbollah drone attack on an Israeli army base near Binyamina. The trials were attended by Defense Minister Yoav…

  • Sanofi MS drug tolebrutinib misses goal in relapsing disease trials By Reuters

    By Ludwig Berger (Reuters) – Sanofi Nasdaq:NASDAQ:NASDAQ:MSN’S most advanced multiple sclerosis drug failed to meet the main goal of two late-stage trials to treat recurrent forms of the disease, dimming the prospects for a broad class of drugs. The French drugmaker said on Monday that two phase 3 trials showed…

  • Russia nears crypto exchange trials to bypass sanctions: report

    Russia is reportedly set to begin experiments on cryptocurrency exchanges and token transactions for cross-border payments to mitigate the impact of international sanctions. Russia appears to be days away from starting trials of cryptocurrency exchanges and token transactions for cross-border transactions in an attempt to bypass the challenges it faces…

  • Boeing begins 777-9 certification flight trials with US FAA By Reuters

    (Reuters) – Boeing Co has begun flight tests of its long-awaited 777-9 jetliner with U.S. aviation regulators on board, the U.S. planemaker said in an emailed statement. The company said it made its first flight on Friday evening after receiving its Type Inspection Authorization (TIA). The development is a boost…

  • Hong Kong Trials China’s e-CNY

    Hong Kong, the dynamic hub of Asian finance, has taken a pioneering leap into the future of digital currency. in This is the first step of its kindChina has launched a pilot program for its electronic currency CNY, or digital yuan, allowing Hong Kong residents to test this new financial…

  • BioAtla reports promising data in cancer drug trials By Investing.com

    BioAtla, a biotechnology company, has announced its first-quarter financial results and provided a business update, highlighting positive data from ongoing clinical trials and the potential for strategic partnerships. The company showcased encouraging results from its CAB-ROR2-ADC drug in treating head and neck cancer and is preparing for FDA guidance on…

  • Gritstone bio details progress in cancer vaccine trials By Investing.com

    Gritstone bio (GRTS) has unveiled promising preliminary data from its GRANITE personalized cancer vaccine program during its First Quarter 2024 Earnings Call. The clinical updates showed a positive trend in progression-free survival (PFS) for colorectal cancer patients, with particularly encouraging results in high-risk individuals. The company’s financial position was also…